Clincosm LogoSign in Get a demo

ovarian cancer

Showing 1 - 25 of 1,589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in France (tests to determine HRD status)

Not yet recruiting
  • Ovarian Cancer
  • tests to determine HRD status
  • Amiens, France
  • +3 more
Nov 22, 2023

Ovarian Cancer Trial in Shanghai (mobile online support group (experiment group), offline support group (control group))

Completed
  • Ovarian Cancer
  • mobile online support group (experiment group)
  • offline support group (control group)
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong Universiy
Nov 21, 2023

Ovarian Cancer Trial in Madrid (Exercise and dietary recommendations)

Not yet recruiting
  • Ovarian Cancer
  • Exercise and dietary recommendations
  • Madrid, Spain
  • +3 more
Nov 15, 2023

The Registry of Genetic Alterations of Taiwan Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
    • Kaohsiung, Taiwan
    • +7 more
    Nov 8, 2023

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

      Recruiting
      • Ovarian Cancer
      • Biomolecular profiling
      • Helsinki, Finland
        Helsinki University and Helsinki University Hospital
      Nov 1, 2023

      Shanghai Ovarian Cancer and Family Care Project

      Recruiting
      • Ovarian Cancer
        • Shanghai, Shanghai, China
          Shanghai first maternity and infant hospital
        Oct 31, 2023

        New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

        Enrolling by invitation
        • Ovarian Cancer
        • +2 more
        • CRS scoring
        • Routine blood laboratory testing before treatment
        • Guangzhou, Guangdong, China
          The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
        Nov 2, 2023

        Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

        Not yet recruiting
        • Ovarian Cancer
        • Olaparib tablet
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Nov 1, 2023

        Doppler Ultrasound and CT Versus Laparoscopy in Assessment of

        Recruiting
        • Ovarian Cancer
        • Laparoscopy
        • Mansoura, Dakahlia, Egypt
          Mansoura University Hospital
        Oct 25, 2023

        Prospective RegIstration Of peRformance of IoTa ADNEX Model in

        Recruiting
        • Ovarian Tumor
        • Ovarian Cancer
        • Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasound in according with the IOTA definitions is performed.
        • Veldhoven, Noord-Brabant, Netherlands
          Máxima Medical Centre
        Oct 25, 2023

        Ovarian Cancer Trial in Roma (Blood sample)

        Recruiting
        • Ovarian Cancer
        • Blood sample
        • Roma, Italy
          Policlinico Universitario Agostino Gemelli
        Oct 10, 2023

        Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

        Not yet recruiting
        • Ovarian Cancer
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 9, 2023

        Ovarian Cancer Trial in Roma (Blood samples)

        Not yet recruiting
        • Ovarian Cancer
        • Blood samples
        • Roma, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Oct 3, 2023

        Ovarian Cancer Trial in Rome (Tumor biopsy)

        Recruiting
        • Ovarian Cancer
        • Tumor biopsy
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Oct 2, 2023

        Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

        Not yet recruiting
        • Breast Cancer
        • +7 more
        • (no location specified)
        Sep 26, 2023

        Ovarian Cancer Trial in Turku (KAND145, Placebo)

        Not yet recruiting
        • Ovarian Cancer
        • Turku, Finland
          Clinical Research Services Turku - CRST Oy
        Sep 26, 2023

        Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

        Not yet recruiting
        • Ovarian Cancer
        • +4 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Cetntre
        Sep 25, 2023

        Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

        Not yet recruiting
        • Solid Tumor, Adult
        • +19 more
        • A2B694
        • xT CDx with HLA-LOH Assay
        • Duarte, California
        • +9 more
        Sep 22, 2023

        Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,

        Recruiting
        • Triple Negative Breast Cancer
        • +5 more
        • Austin, Texas
        • +2 more
        Sep 19, 2023

        Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

        Recruiting
        • Advanced Solid Tumor
        • +8 more
        • CNSI-Fe(II) 30 mg
        • +2 more
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Sep 15, 2023

        Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)

        Not yet recruiting
        • Ovarian Cancer
        • Malignant Neoplasm of Uterus
        • New York, New York
          Icahn School of Medicine at Mount Sinai Division of Hematology a
        Sep 14, 2023

        A Real-World Patient-Reported Outcomes Study in Long-Term Use of

        Recruiting
        • Ovarian Cancer
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Sep 13, 2023

          Ovarian Cancer Trial in Houston (Shared Medical Decision Tool, Engaging Patients in Decision Making, Literacy Spanish Language)

          Recruiting
          • Ovarian Cancer
          • Shared Medical Decision Tool
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Sep 7, 2023

          PRO for Fighting FT in Ovarian Cancer

          Not yet recruiting
          • Ovarian Cancer
          • Questionnaires
          • Naples, Italy
            Nation Cancer Institute of Naples, Division of Medical Oncology
          Sep 13, 2023